Effectiveness of the 2023 Autumn XBB.1.5 COVID‐19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study
XBB.1.5 vaccination provided minimal residual protection against severe COVID-19 outcomes among adults aged ≥ 65 years more than 6 months after vaccination, during the summer 2024 period of increased SARS-CoV-2 activity.
Authors
- James Humphreys
- Toon Braeye (ORCID: https://orcid.org/0000-0002-5637-4613)
- Ida Rask Moustsen‐Helms (ORCID: https://orcid.org/0000-0002-1143-511X)
- Esther Kissling (ORCID: https://orcid.org/0000-0001-7188-8404)
- Susana Monge (ORCID: https://orcid.org/0000-0003-1412-3012)
- Nicklas Pihlström (ORCID: https://orcid.org/0000-0001-6812-0971)
- Izaak Van Evercooren
- Massimo Fabiani (ORCID: https://orcid.org/0000-0002-5893-7117)
- Sabrina Bacci (ORCID: https://orcid.org/0000-0002-6575-3439)
- Ausenda Machado (ORCID: https://orcid.org/0000-0002-1849-1499)
- Nathalie Nicolay (ORCID: https://orcid.org/0000-0002-5916-7855)
- Chiara Sacco (ORCID: https://orcid.org/0000-0002-3958-8353)
- Christian Holm Hansen (ORCID: https://orcid.org/0000-0002-5949-0097)
- Anthony Nardone (ORCID: https://orcid.org/0000-0003-1138-0937)
- Patrícia Soares (ORCID: https://orcid.org/0000-0001-5033-9115)
- Rickard Ljung (ORCID: https://orcid.org/0000-0002-0654-4530)
- Iván Martínez‐Baz (ORCID: https://orcid.org/0000-0002-3405-2277)
- Baltazar Nunes (ORCID: https://orcid.org/0000-0001-6230-7209)
Institutions
- Statens Serum Institut (DK)
- Medical Products Agency (SE)
- Istituto Superiore di Sanità (IT)
- Instituto de Salud Carlos III (ES)
- Karolinska Institutet (SE)
- Instituto de Salud Pública de Navarra (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Instituto Nacional de Saúde (MZ)
- Sciensano (Belgium) (BE)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Influenza and Other Respiratory Viruses
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1111/irv.70198
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Centre for Disease Prevention and Control
- Fundação para a Ciência e a Tecnologia